Industry / Switzerland
Focus On Medical Devices
March 2008 | Industry NewsSwitzerland's medical device market is highly developed and was worth approximately US$4.1bn in 2007. By 2012 the market should reach a value of US$5.2bn, representing a compound annual growth rate (CAGR) of around 5%, which is roughly in line with growth in the pharmaceutical market. Like Switzerland's drug sector, the medical devices industry is characterised by impressive technological standards and a high density of operators. Imports make up around 60% of the medical devices market, with US firms accounting for the majority of this
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
